Chuntao T. Tian
Sanmenxia, 472000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Interim analysis of a prospective, multicenter, clinical trial of oxycodone naloxone prolonged-release tablets for severe cancer pain complicated with opioid-induced constipation
Journal: Zhonghua yi xue za zhi
Published: July 21, 2026
Effects of lncRNA DHRS4-AS1 on proliferation, invasion, migration, and apoptosis of thyroid cancer cells by regulating the miR-221-3p/SOCS3 signaling axis
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: September 17, 2025
Qiu's Cervical Prescription inhibit the invasion and growth of cervical cancer through LncRNA ATB/miR-126 pathway.
Journal: Pathology, research and practice
Published: December 08, 2024
A patient with BRAF N581S mutation-positive lung adenocarcinoma demonstrates durable response to combined anlotinib and tislelizumab: A case report and literature review.
Journal: Pathology, research and practice
Published: December 25, 2023
OTX1 regulates tumorigenesis and metastasis in glioma.
Journal: Pathology, research and practice
Published: December 14, 2023
Establishment of a predictive model for breast cancer chemotherapy efficacy and prognosis based on immune microenvironment molecules.
Journal: Minerva medica
Published: August 01, 2023
Improved intracellular delivery of exosomes by surface modification with fluorinated peptide dendrimers for promoting angiogenesis and migration of HUVECs.
Journal: RSC advances
Published: January 15, 2023
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 04, 2023
UCHL1 promotes cancer stemness in triple-negative breast cancer.
Journal: Pathology, research and practice
Published: November 01, 2022
Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01).
Journal: Annals of translational medicine
Published: October 12, 2022
The cancer-testis antigen FBXO39 predicts poor prognosis and is associated with stemness and aggressiveness in glioma.
Journal: Pathology, research and practice
Published: September 13, 2022
Development of an Independent Prognostic Signature Based on Three Hypoxia-Related Genes for Breast Cancer.
Journal: Computational and mathematical methods in medicine
Published: June 23, 2022
Last Updated: 09/26/2026